Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments

DSpace Repository

Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments

Author: Latus, Joerg; Klein, Reinhild; Koetter, Ina; Schwab, Matthias; Fritz, Peter; Kimmel, Martin; Alscher, M. Dominik; Braun, Niko
Tübinger Autor(en):
Klein, Reinhild
Schwab, Matthias
Published in: Plos One (2013), Bd. 8, Article e78856
Verlagsangabe: Public Library Science
Language: English
Full text: http://dx.doi.org/10.1371/journal.pone.0078856
ISSN: 1932-6203
DDC Classifikation: 500 - Natural sciences and mathematics
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)